Abstract
Purpose
Hypertrophic cardiomyopathy (HCM) is a hereditary disease characterised by primary hypertrophy of the left and/or right ventricle. The reference standard for imaging diagnosis is echocardiography. The aim of our study was to prospectively compare the diagnostic accuracy of echocardiography and cardiac magnetic resonance (MR) imaging in patients with HCM.
Materials and methods
Twenty-two consecutive patients with a known diagnosis of HCM were prospectively evaluated, with echocardiography and cardiac MR imaging performed within 2 weeks of each other (mean interval 7 days, range 2–14 days). Two experienced radiologists blinded to the previous clinical and imaging findings separately reviewed the images. The following parameters were calculated for both techniques: myocardial mass, wall thickness, end-diastolic volume (EDV), end-systolic volume (ESV), ejection fraction (EF), systolic anterior motion (SAM) of the mitral valve and degree of myocardial fibrosis (based on the ultrasonic reflectivity at echocardiography and degree of late enhancement at cardiac MR imaging). The statistical correlation was calculated with Student’s t test, Spearman coefficient and Fisher’s exact test. A value of p<0.05 was considered significant.
Results
The diagnosis of HCM was confirmed in all patients with both techniques, with absolute agreement in terms of the site of disease. The mean value of myocardial mass presented a statistically significant difference between the two techniques (114 g, p<0.001). In contrast, a nonsignificant difference between echocardiography and cardiac MR imaging was found for EDV (102 ml vs 111 ml; p=0.31), ESV (30 ml vs 38 ml; p=0.1), EF (74% vs 68%, p=0.5), SAM (p=0.1) and myocardial fibrosis (p=0.15).
Conclusions
Cardiac MR imaging correlates well with echocardiography in defining the morphological and functional parameters useful for the imaging diagnosis of HCM and therefore, in selected cases (poor acoustic window, doubtful echocardiography findings), it may be a valid alternative to echocardiography.
Riassunto
Obiettivo
La cardiomiopatia ipertrofica (CMI) è una malattia ereditaria caratterizzata dalla primitiva ipertrofia del ventricolo sinistro e/o destro. Lo standard di riferimento per la diagnosi strumentale è rappresentato dall’eco-cardiografia. Il nostro scopo è confrontare prospetticamente l’accuratezza diagnostica di ecocardiografia e risonanza magnetica cardiaca (cardio-RM) in pazienti con CMI.
Materiali e metodi
Ventidue pazienti consecutivi con diagnosi nota di CMI sono stati prospetticamente valutati mediante eco-cardiografia e cardio-RM eseguite entro 2 settimane (scarto medio 7 giorni, range 2–14 giorni). Due operatori esperti, non a conoscenza dei precedenti dati clinici e strumentali dei pazienti arruolati, hanno revisionato separatamente le immagini. Per entrambe le tecniche sono stati calcolati massa cardiaca, spessori di parete, volume telediastolico (VTD) e telesistolico (VTS), frazione di eiezione (FE), spostamento anteriore del lembo mitralico (SAM), grado di fibrosi parietale (basato sul valore di eco-rinfrangenza all’eco-cardiografia e sull’entità di impregnazione tardiva alla cardio-RM). La correlazione statistica è stata calcolata mediante test t di Student, R di Spearman e test di Fisher. Un valore di p<0,05 è stato considerato significativo.
Risultati
La diagnosi di CMI è stata confermata in tutti i pazienti con entrambe le metodiche, con concordanza assoluta per quanto riguarda la sede. Il valore medio della massa cardiaca ha presentato una differenza statisticamente significativa tra le due metodiche (114 g, p<0,001). Al contrario, una differenza non significativa fra eco-cardiografia e cardio-RM è stata riscontrata per i valori di VTD (102 ml vs 111 ml; p=0,31), VTS (30 ml vs 38 ml; p=0,1), frazione d’eiezione (74% vs 68%, p=0,5), SAM (p=0,1), fibrosi parietale (p=0,15).
Conclusioni
La cardio-RM correla bene con l’ecocardiografia nella definizione dei parametri morfologici e funzionali utili per la diagnosi strumentale di CMI e può pertanto rappresentare, in casi selezionati (scarsa finestra acustica, rilievi eco-cardiografici dubbi), una valida alternativa all’eco-cardiografia.
Similar content being viewed by others
References/Bibliografia
Wigle ED, Rakowski H, Kimball BP et al (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92:1680–1692
Maron BJ, Gardin JM, Flack JM et al (1995) Prevalence of hypertrophic cardiomyopathy in a population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA study. Coronary Artery Risk Development in (young) adults. Circulation 92:785–789
Jarcho JA, McKena WJ, Pare JA et al (1989) Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. N Engl J Med 321:1372–1378
Pellnitz C, Geier C, Perrot A et al (2005) Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients. Dtsch Med Wochenschr 130:1150–1154
Syed IS, Ommen SR, Breen JF et al (2008) Hypertrophic cardiomyopathy: identification of morphological subtypes by echocardiography and cardiac magnetic resonance imaging. JACC Cardiovasc Imaging 1:377–379
Tam JW, Shaikh N, Sutherland E (2002) Echocardiographic assessment of patients with hypertrophic and restrictive cardiomyopathy: imaging and echocardiography. Curr Opin Cardiol. 17:470–477
Earls JP, Ho VB, Foo TK et al (2002) Cardiac MRI: recent progress and continued challenges. J Magn Reson Imaging 16:111–127
Bicudo LS, Tsutsui JM, Shiozaki A et al (2008) Value of real time three-dimensional echocardiography in patients with hypertrophic cardiomyopathy: comparison with two-dimensional echocardiography and magnetic resonance imaging. Echocardiography 25:717–726
Aquaro GD, Masci P, Formisano F et al (2010) Usefulness of delayed enhancement by magnetic resonance imaging in hypertrophic cardiomyopathy as a marker of disease and its severity. Am J Cardiol 105:392–397
Payá E, Marín F, González J et al (2008) Variables associated with contrast-enhanced cardiovascular magnetic resonance in hypertrophic cardiomyopathy: clinical implications. J Card Fail 14:414–419
Dimitrow PP, Klimeczek P, Vliegenthart R et al (2008) Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Int J Cardiovasc Imaging 24:77–83
Rubinshtein R, Glockner JF, Ommen SR et al (2010) Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy. Circ Heart Fail 3:51–58
Kwon DH, Smedira NG, Rodriguez ER et al (2009) Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. J Am Coll Cardiol 54:242–249
Weyman AE (1994) Principals and practice of echocardiography. Lea & Febiger, Philadelphia
Afonso LC, Bernal J, Bax JJ, Abraham TP (2008) Echocardiography in hypertrophic cardiomyopathy: the role of conventional and emerging technologie. JACC Cardiovasc Imaging 1:787–800
Carsten R, Norbert M, Michael J et al (2005) Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 112:855–861
Fattori R, Biagini E, Lorenzini M et al (2010) Significance of magnetic resonance imaging in apical hypertrophic cardiomyopathy. Am J Cardiol 105:1592–1596
Moon JC, Fisher NG, McKenna WJ et al (2004) Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography. Heart 90:645–649
Marcus JT, Götte MJ, DeWaal LK et al (1998) The influence of through-plane motion on left ventricular volumes measured by magnetic resonance imaging: implications for image acquisition and analysis. J Cardiovasc Magn Reson 1:1–6
Kwon DH, Desai MY (2010) Cardiac magnetic resonance in hypertrophic cardiomyopathy: current state of the art. Expert Rev Cardiovasc Ther 8:103–111
Factor SM, Butany J, Sole MJ et al (2000) Pathologic fibrosis and matrix connective tissue in the subaortic myocardium of patiens with hypertrophic cardiomyopathy. J Am Coll Cardiol 35:36–44
Esposito A, De Cobelli F, Perseghin G et al (2009) Impaired left ventricular energy metabolism in patients with hypertrophic cardiomyopathy is related to the extension of fibrosis at delayed gadolinium-enhanced magnetic resonance imaging. Heart 95:228–233
Bergey PD, Axel L (2000) Focal hypertrophic cardiomyopathy simulating a mass: MR tagging for correct diagnosis. AJR Am J Roentgenol 174:242–244
Ligabue G, Fiocchi F, Ferraresi S et al (2008) 3-Tesla MRI for the evaluation of myocardial viability: a comparative study with 1.5-Tesla MRI. Radiol Med 113:347–362
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guarise, A., Faccioli, N., Foti, G. et al. Role of echocardiography and cardiac MRI in depicting morphological and functional imaging findings useful for diagnosing hypertrophic cardiomyopathy. Radiol med 116, 197–210 (2011). https://doi.org/10.1007/s11547-010-0603-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-010-0603-3